You are here: Home > News & Events > News

The list of 20 most cited articles published in the Journal of Hepatology include 4 documents by IDIBAPS – Hospital Clínic investigators

21/10/2013

The Journal of Hepatology is the official journal of the European Association for the Study of the Liver (EASL), and a key resource in the specialty. With each issue this Journal publishes original papers, reviews, case reports and letters to the Editor concerned with clinical and basic research in the field of hepatology. 

Read more about "The list of 20 most cited articles published in the Journal of Hepatology include 4 documents by IDIBAPS – Hospital Clínic investigators"

CommHERE - Invitation to HorizonHealth launch

---- ---- Invitation Web for the public The EU project Communicating European Health Research, CommHERE, invites you to the official opening of a new health research web portal, targeting the general public. The portal will put European citizens in touch with research by presenting FP7 Health research in an attractive and inspiring way. Join our network The launch of the web portal is a crucial part of the CommHERE project, enabling dissemination of research on a European level. From working on local levels at the CommHERE partner institutions, we now open up and invite all EU health research projects to participate in our communication network. CommHERE in short: • Aims to improve communication on the outcome of EU funded health research projects to the media, general public and other target groups, including the EC in all of Europe and beyond. • Works by supporting and encouraging researchers to communicate also outside of the scientific community. • Duration: 36 months, from October 2011 to September 2014 • Funding: 2 million Euro • Project web site: www.commhere.eu

Dr. Augusto Villanueva and Dr. Francesc Balaguer awarded Rising Stars by United European Gastroenterology (UEG) National Societies

Every year the United European Gastroenterology (UEG) National Societies Committee and the Scientific Committee jointly select up to 10 emerging clinical scientists. In the 2013 edition of the Rising Star awards two IDIBAPS investigators are among the winners: Dr.Augusto Villanueva, from the IDIBAPS Hepatocellular Carcinoma Translational Research Lab (BCLC group), and Dr. Francesc Balaguer, from the IDIBAPS Gastrointestinal and Pancreatic Oncology team. The awarded researchers are young and highly qualified professionals from around Europe with a relevant international-quality research. This initiative provides a durable platform for young researchers so that they can give state-of-the-art lectures and chair scientific sessions at UEG Week. The next one will take place on October 12-16, in Berlin. 

Read more about "Dr. Augusto Villanueva and Dr. Francesc Balaguer awarded Rising Stars by United European Gastroenterology (UEG) National Societies"

Notch signaling promotes liver carcinogenesis becoming an appealing target for new therapies

Less than 30% of newly diagnosed hepatocellular carcinoma (HCC) patients are eligible for curative therapies such as resection, liver transplantation, or local ablation. Hence, there is an increasing need to develop new drugs for a disease that, besides being the third leading cause of cancer death worldwide, has tripled its incidence in the last decades in the United States. An article published in Gastroenterology by the IDIBAPS Translational Research in Hepatic Oncology group, led by the ICREA investigator Prof Josep Maria Llovet, demonstrates that Notch signaling is activated in a subset of human HCC samples, and promotes liver tumor formation in genetically engineered mice. In addition, the study reports a Notch gene signature able to predict response to Notch inhibition in experimental models of liver cancer. First authorship of the manuscript is shared by Dr Augusto Villanueva and Clara Alsinet. The study is the result of an international collaboration that includes renown leaders in the field from the University of Pennsylvania (Philadelphia), the Broad Institute and Dana-Farber Cancer Institute at Harvard Medical School (Boston), and Mount Sinai School of Medicine (New York).

Read more about "Notch signaling promotes liver carcinogenesis becoming an appealing target for new therapies"

Prof Manel Esteller - Hosted by: Prof Josep M Llovet

IDIBAPS SEMINAR - Lecture: Cancer Epigenetics and BiologyProgram

Venue: Esteve Auditorium, CEK Building Rosselló, 153  Barcelona 08036 Time: 15h Tel: 93 2274506

Prof Llovet invited to participate at the EU Grant Session at EASL

Berlin, April 2011

Prof Llovet was invited to participate as speaker at the EU Grant Session: “Improving Liver Research Funding from the EU” which was held on Friday, April 1, 2011 during the International Liver Congress by EASL in Berlin, Germany from March 30th – April 3rd, 2011. This new initiative aimed to promote and exchange the numerous programmes, projects and support that are carried out at EU level. Prof Llovet gave a talk that presented his experience as Principal Investigator within a European project and explained how is the Heptromic Project the first European Research project centred specifically on the genomics of this type of cancer.

Read more about "Prof Llovet invited to participate at the EU Grant Session at EASL"

Watch the HEPTROMIC video

The HEPTROMIC video was presented during the kick-off meeting of the Project, which took place yesterday in Barcelona

The HEPTROMIC video was presented during the kick-off meeting of the Project, which took place yesterday in Barcelona. Its main objective is to explain the goals and the project and the outstanding team that will make it possible.

Read more about "Watch the HEPTROMIC video"

HEPTROMIC kick-off meeting. A new approach to Hepatocellular Carcinoma

The first research network funded by the European Commission devoted to the study of Hepatocellular Carcinoma

November 22nd

HEPTROMIC is the first research network funded by the European Commission devoted to the study of Hepatocellular Carcinoma (HCC). It is a 3-year translational research project which aims to solve core problems in the management of HCC, the third most common cause of cancer-related death worldwide. The partners taking part in this initiative have met today in Barcelona in the called kick-off meeting, which officially starts the project. Dr. Josep Maria Llovet, ICREA Research professor at IDIBAPS - Hospital Clínic, and his team lead that project which is meant to change the treatment of this cancer in the next years.

Read more about "HEPTROMIC kick-off meeting. A new approach to Hepatocellular Carcinoma"

Project led by: Idibaps

Copyright © 2010 - 2017 HEPTROMIC

HEPTROMIC is a project in the 'Health' Theme of the Specific Programme 'Cooperation' of the European Commission's Seventh Framework Programme.